S. Ohmori
- Pharmacology top 1%
- Environmental Chemistry top 5%
- Molecular Biology
- Oncology
- Health, Toxicology and Mutagenesis top 10%
- Co-authors
- Munehiro KitadaKazuei IgarashiMariyo F. WatanabeIkuko I. OhtaniMasayuki WatanabeKen‐ichi HaradaK. TERAOE. Ito
- Topics
- Pharmacogenetics and Drug Metabolism (15 papers)Drug-Induced Hepatotoxicity and Protection (4 papers)Eicosanoids and Hypertension Pharmacology (4 papers)
- Journals
- Biochemical and Biophysical Research CommunicationsJournal of Pharmacology and Experimental TherapeuticsArchives of Biochemistry and Biophysics
- Partner nations
- JapanUnited StatesCzechia
In The Last Decade
S. Ohmori
25 papers receiving 845 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 359
- Environmental Chemistry 242
- Molecular Biology 188
- Oncology 181
- Health, Toxicology and Mutagenesis 109
Countries citing papers authored by S. Ohmori
This map shows the geographic impact of S. Ohmori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Ohmori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Ohmori more than expected).
Fields of papers citing papers by S. Ohmori
This network shows the impact of papers produced by S. Ohmori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Ohmori. The network helps show where S. Ohmori may publish in the future.
Co-authorship network of co-authors of S. Ohmori
This figure shows the co-authorship network connecting the top 25 collaborators of S. Ohmori. A scholar is included among the top collaborators of S. Ohmori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Ohmori. S. Ohmori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 0 | |
| 3 | 43 | |
| 4 | 13 | |
| 5 | Steroid hydroxylation by human fetal CYP3A7 and human NADPH-cytochrome P450 reductase coexpressed in insect cells using baculovirus. | 24 |
| 6 | An excessive accumulation of olfactory calcium and inhibition of olfactory signal transduction by organotin compounds | 2 |
| 7 | 10 | |
| 8 | 1 | |
| 9 | 284 | |
| 10 | 13 | |
| 11 | 11 | |
| 12 | 2 | |
| 13 | 33 | |
| 14 | 42 | |
| 15 | 21 | |
| 16 | 21 | |
| 17 | 52 | |
| 18 | 15 | |
| 19 | 24 | |
| 20 | Formation of reductive metabolite, 2-sulfamoylacetylphenol, from zonisamide in rat liver microsomes. | 6 |
About S. Ohmori
S. Ohmori is a scholar working on Pharmacology, Biochemistry and Pharmaceutical Science, having authored 27 papers that have together received 881 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (15 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). The work is most often cited by research in Pharmacology (359 citations), Environmental Chemistry (242 citations) and Biochemistry (59 citations). S. Ohmori has collaborated with scholars based in Japan, United States and Czechia. Frequent co-authors include Munehiro Kitada, Kazuei Igarashi, Mariyo F. Watanabe, Ikuko I. Ohtani, Masayuki Watanabe, Ken‐ichi Harada, K. TERAO, E. Ito, Hiromitsu Nakasa and S. Narimatsu. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.